RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
肿瘤细胞治疗研究
英文原题:Surface Engineering of NK Cells with Poly-L-Glutamic Acid Enhances Tumor-Selective Immunotherapy Against Ovarian Cancer.
Surface Engineering of NK Cells with Poly-L-Glutamic Acid Enhances Tumor-Selective Immunotherapy Against Ovarian Cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
自然杀伤(NK)细胞是癌症免疫治疗中具有前景的效应细胞,因为它们无需预先抗原致敏即可识别并消灭肿瘤细胞。然而,肿瘤识别不足仍然是一个关键限制,降低了NK细胞对实体瘤的抗癌疗效。为解决这一限制,我们开发了一种脂质介导的细胞膜工程策略,以增强NK细胞对实体瘤尤其是卵巢癌细胞的靶向和细胞毒效能。在该策略中,聚-L-谷氨酸(PLE)被用作卵巢癌靶向模块,因为PLE对富含胆固醇的膜结构域具有特异性亲和力。为将PLE展示在NK细胞上,引入脂质部分通过疏水插入将PLE锚定到NK细胞膜上,从而实现快速且非基因的表面修饰。结果,表面工程化修饰PLE-Lipid的NK细胞(即PLE-NK)在NK细胞表面展示PLE,使其能够直接识别卵巢癌细胞,而不损害NK细胞的固有特性。这种增强的识别随后通过促进NK细胞膜展示的PLE与卵巢癌细胞上胆固醇之间的相互作用,增加了NK-癌细胞簇的形成。
因此,PLE-NK细胞对卵巢癌细胞(即OVCAR-3细胞)表现出增强的细胞毒性,并有效破坏3D肿瘤球,而PLE-NK细胞对正常成纤维细胞未显示脱靶效应。
总体而言,这些发现表明PLE-Lipid介导的NK表面工程提供了一种简单有效的策略来提高NK细胞的肿瘤靶向能力,并为针对卵巢癌的NK细胞免疫治疗提供了一个有前景的平台。
Natural killer (NK) cells are promising effectors for cancer immunotherapy, as they can recognize and eliminate tumor cells without prior antigen sensitization.
However, insufficient tumor recognition remains a critical limitation that reduces the anticancer efficacy of NK cells against solid tumors. To address this limitation, we developed a lipid-mediated cell membrane engineering strategy to enhance the targeting and cytotoxic efficacy of NK cells toward solid tumors, particularly ovarian cancer cells. In this strategy, poly-L-glutamic acid (PLE) was employed as an ovarian cancer-targeting module due to the specific affinity of PLE for cholesterol-rich membrane domains. To display PLE on NK cells, a lipid moiety is incorporated to anchor PLE onto the NK cell membrane via hydrophobic insertion, enabling rapid and non-genetic surface modification. As a result, the surface-engineered NK cells with PLE-Lipid (i. e.
, PLE-NK) displayed PLE on the NK cell surface, allowing direct recognition of ovarian cancer cells without compromising the intrinsic properties of NK cells. This enhanced recognition subsequently increased NK-cancer cluster formation by promoting interactions between membrane-presented PLE on NK cells and cholesterol on ovarian cancer cells. Consequently, PLE-NK cells exhibited enhanced cytotoxicity against ovarian cancer cells (i.
e. , OVCAR-3 cells) and effectively disrupted 3D tumoroids, while PLE-NK cells showed no off-target effects on normal fibroblasts. Collectively, these findings demonstrate that PLE-Lipid-mediated NK surface engineering provides a simple and effective strategy to improve the tumor targeting ability of NK cells and offers a promising platform for NK cell-based immunotherapy against ovarian cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。